A 35-year-old woman was diagnosed as autoimmune hepatitis 12 years ago by abnormal findings of liver tests including lupus erythematosus (LE) cell phenomenon and liver biopsy. She was admitted in May 1990 with a history of lower gastrointestinal bleeding. Colonoscopy with biopsy and barium enema revealed chronic ulcerative colitis along the entire colon. Since liver tests did not respond well to prednisolone treatment, liver biopsy was again performed and it revealed periductal inflammation with small duct proliferation, a finding compatible with pericholangitis. We herein report this patient who was initially diagnosed as autoimmune hepatitis and thereafter found to be pericholangitis associated with ulcerative colitis.
Introduction
Chronic active liver disease with lupus erythematosus (L.E.) cell phenomenon h §s been considered to be in a category referred to as autoimmune hepatitis (1) . Other autoimmune diseases such as ulcerative colitis (2, 3) , may be associated with the disease during the clinical course. Although the disease is almost always responsive to corticosteroids, many patients eventually relapse years later as autoimmune hepatitis. However, it is not well known that pericholangitis, the characteristic of which is peri-ductal inflammation in the portal fields, may occur after a longterm clinical course of autoimmune hepatitis. We recently treated a patient who was initially diag nosed as autoimmune hepatitis and thereafter found to be pericholangitis by liver biopsy and clinical features. Furthermore, the patient was found to have accompanying chronic ulcerative colitis. We present this case since it is interesting that autoimmune hepatitis was clinically and histologically given place to pericholangitis which seems to be associated with ulcerative colitis (4, 5) .
Case Report
A 35-year-old Japanese female was admitted to Kobe University Hospital in May 1990 with a 5-day previous history of massive bleeding from the lower gastrointestinal tract accompanied by hypovolemic shock. In February 1979, she had been admitted to Kobe University Hospital because of low grade fever and jaundice. At that time, she was diagnosed as autoimmune hepatitis on the basis of liver tests with liver biopsy. The serum alkaline phosphatase activity 8U (Bessy Lowry method, normal 1.2-2.9); SGOT 820 KU (normal 8-40), SGPT 457 KU (normal 5-35), total bilirubin 2.0mg/dl, total protein 10.4g/dl, albumin 3.4g/dl and a diffuse hypergammaglobulinemia with IgG of 5628 mg/dl, IgA of 447mg/dl and IgM of 172mg/dl. Anti-nuclear anti body, anti-DNA antibody and anti-smooth muscle anti body were all positive. Although LE cell phenomenon was absent at that time, one of four LE preparations became positive later. Specimens of a liver biopsy per formed showed infiltration into the hepatic lobules of inflammatory cells mainly constituting of plasma cells, suggesting the existence of chronic active hepatitis (Fig. 1) . Hepatitis B serologies were absent. Therefore, she was diagnosed as autoimmune hepatitis and treated with prednisolone 30 mg daily for 4 weeks. She responded well to the treatment and she was discharged on pre dnisolone 10mg daily on May 1981 (Fig. 2) . Thereafter, she continued to undergo medical follow-up. The patient occasionally experienced recurrent episodes of diarrhea during the 6 subsequent years. Since 1987, the activities of serum alkaline phosphatase and y-glutamyl transpeptidase gradually became elevated even though the patient continued to take 7.5mg-12.5mg of pred nisolone daily (Fig. 2) . Six days prior to admission in May 1990, there were no clinical symptoms such as diarrhea, abdominal pain or fever. On admission, she had no guarding of abdominal muscles and tenderness, but an elastic firm non-tender and non-nodular liver was palpable with a span of 1.5 cm in the mid clavicular line. Rectal examination revealed no mass, but the stool showed had a trace of blood. Initial laboratory data included an ESR of 46mm/h, hemoglobin 9.7 g/dl, a white blood cell count 9,900/mm3, and a platelet count 323,000/mm3. The serum alkaline phosphatase activity was 664 IU/1; total bilirubin 0.7 mg/dl, SGOT 103 IU/1, SGPT 139IU/1, y-glutamyl transpepti dase 671 IU/1, total protein 6.0g/dl and albumin 3.3 g/dl.
IgG was 1643mg/dl; IgA 260mg/dl and IgM 166mg/dl. Anti-nuclear antibody was still positive, but anti-smooth muscle and anti-DNA antibodies were absent this time. Anti-mitochondrial antibody was also absent. Hepatitis B and Hepatitis C virus serologies were all absent. Barium enema showed a slight shortening of the bowel with inflammatory polyps. Colonoscopy to ceacum revealed slightly dry mucosa with inflammatory polyps and indis tinct vascular pattern of the mucosa along the entire colon and rectosigmoid, although it did not reveal the location of the bleeding (Fig. 3) . Pathological examination of a colonic biopsy revealed distorted crypt architectures and crypt atrophy with inflammatory cell infiltration, a finding consistent with chronic ulcerative colitis (data not shown).
On the 30th hospital day, prednisolone was increased to 30mg daily for the treatment of liver dysfunction and chronic ulcerative colitis. However, SGOT and SGPT did not return to normal and y-glutamyl transpeptidase acti vity increased from 669IU/1 to 1,092IU/1 in the course of next 4 weeks (Fig. 2) . To clarify unresponsiveness of liver tests to prednisolone and compare pathological findings of the liver with those obtained previously, a liver biopsy was performed again and revealed a finding compatible with pericholangitis. There was no expansion of inflammatory cells into the hepatic lobule and no destruction of the hepatocytes located around the lobule (Fig. 4) . Endoscopic retrograde cholangiography showed that the common bile duct was possibly partially sclerotic, although primary sclerosing cholangitis could not be diagnosed by these findings (Fig. 5 ). Since the patient had no major systemic complaints, prednisolone was decreased to 15mg per day 4 months after admission. Although the patient continued to take 12.5 mg ~ 15 mg of prednisolone per day thereafter, liver dysfunction (alph 477IU, yGTP 262IU, SGOT 58IU, SGPT 100IU) is still present in January 1992. We presented a patient whose clinical features of pericholangitis associated with ulcerative colitis were complicated by her past history of autoimmune hepatitis. The patient was initially diagnosed by liver tests with liver biopsy as autoimmune hepatitis. The diagnostic criteria including an abnormally high concentration of IgG had been clinically and histologically satisfied at that time. Of interest is the observation that the symptoms and signs of autoimmune hepatitis gradually changed during the clinical course of 12 years. As far as we know, there is no report available which discusses alteration from autoimmune hepatitis to pericholangitis clinically and histologically. This time, abnormally high activities of serum alkaline phosphatase and y-glutamyl transpep tidase were found. The recovery of such abnormalities of liver function tests was very poor in response to pred nisolone treatment as compared with that of an initial treatment. The present case do not seem to be primary biliary cirrhosis, due to the fact that anti-mitochondrial antibody was absent and liver biopsy specimens did not
show non-suppurative destructive cholangitis. On the other hand, the liver biopsy specimen showing periductal lymphocyte infiltration suggests that this patient may be in the first stage of primary sclerosing cholangitis. Recently, it has been suggested that the histological features of pericholangitis may be identical to the liver histology of patients with primary sclerosing cholangitis (6) . 65 to 75% of the primary sclerosing cholangitis may occur in the patients with inflammatory bowel diseases, especially chronic ulcerative colitis (7). Furthermore, occurrence of primary sclerosing cholangitis or peri cholangitis may be related to autoimmune mechanisms. Bodenheimer et al (8) have described elevated circulating immune complexes in patients with primary sclerosing cholangitis. Anti-smooth muscle and anti-nuclear anti bodies have also been described in primary sclerosing cholangitis (9) . Therefore, the present case raises the possibility that pericholangitis may be caused by auto immune mechanisms after a long-term clinical course of autoimmune hepatitis. It has been well known that liver disease is a common complication of chronic inflammatory bowel disease, especially chronic ulcerative colitis (10). Perrett et al (ll) have shown that 45 patients (15%) had an abnor mality of one or more of basic liver tests among 300 patients with chronic ulcerative colitis. They revealed that pericholangitis occurred in 15 patients (5% ) , although fatty change was the most common liver dysfunction occurring in 19 patients (6.3%). Dordal et al (12) as a coexisting disease in 7 of 33 patients with chronic hepatitis which occurred prior to the age of 22 years.
Of the 33 patients they described, 22 were female with a mean serum globulin level of 5.8 ± 2gm/dl, suggesting that liver dysfunction may be related to an autoimmune mechanism. Olsson and Hulten (16) also have shown that 7 of 25 patients with chronic active hepatitis had coexisting ulcerative colitis. Smooth muscle and antinuclear anti bodies were positive in 3 of the 7 patients with ulcerative colitis they described. Judging from these reports, we feel that autoimmune hepatitis may develop ulcerative colitis, although the series reported are extremely small. In summary, we have presented a patient with peri cholangitis associated with ulcerative colitis which occurred presumably through autoimmune mechanisms after a long-term clinical course of autoimmune hepatitis.
